Long-form articles on therapeutic virtual reality, written for clinicians. Applicable in your practice tomorrow. No marketing speak.
How the NHS's gameChange trial paired VR exposure with an automated virtual coach to treat severe agoraphobia — and what it means for private practice.
A clinical review of EMDR and VR integration for trauma treatment: the AIP model, bilateral stimulation inside VR environments, and an honest look at still-limited evidence.
A data-driven 10-year forecast on VR exposure therapy becoming first-line phobia treatment — research funding, regulation, and adoption trends clinics should watch.
A data-driven look at VR exposure therapy adoption in Spanish clinics in 2026: usage rates, the barriers slowing growth, and what NHS and CleVR signal ahead.
How Jeffrey Gray's behavioral inhibition system (BIS) explains OCD avoidance, and how virtual reality can help structure exposure and response prevention (ERP).
How Barlow's tripartite vulnerability model explains why VR exposure activates the same conditioned-fear mechanisms as real exposure, and why presence is the key variable.
Immersion is a technical property; presence is the patient's subjective response. How to measure presence (IPQ, MEC-SPQ) and why headset quality shapes clinical outcomes.
Why VR exposure sees lower dropout than in-vivo therapy: the psychology of perceived control, fine-grained gradation, and documented patient preference.
A narrative review of the major VRET meta-analyses (Powers and Emmelkamp, Opriş, Carl) versus in vivo exposure for anxiety and phobias, including methodological limits.